Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Armando Javier Ruiz‐Justiz has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Angel Isidro

    Department of Basic Sciences, Division of Physiology, Ponce Health Sciences University-Ponce Research Institute, Ponce 00716-2348, Puerto Rico

    1 shared publication
  • Camille Chardón-Colón

    Department of Basic Sciences, Division of Biochemistry, Ponce Health Sciences University-Ponce Research Institute, Ponce 00716-2348, Puerto Rico

    1 shared publication
  • Guillermo N Armaiz-Pena

    Department of Basic Sciences, Division of Pharmacology and Cancer Biology, Ponce Health Sciences University-Ponce Research Institute, Ponce 00716-2348, Puerto Rico

    1 shared publication
  • Harold I. Saavedra

    Department of Basic Sciences, Ponce Health Sciences University-Ponce Research Institute, Ponce, USA

    1 shared publication
  • Jaleisha Vélez-Velázquez

    Department of Biology, University of Puerto Rico-Ponce, Ponce 00716, Puerto Rico

    1 shared publication
  • Juliana Cano‐Mejia

    Bioengineering University of Maryland Washington DC

    1 shared publication

Latest Publications

  • Open Access

    Combined Cataract and Vitrectomy Surgery in Pediatric Patients

    by Armando J. Ruiz-Justiz, Vanessa Cruz-Villegas, Stephen G. Schwartz, Victor M. Villegas, Timothy G. Murray

    Purpose: To review the current literature on the combined use of cataract surgery (or lensectomy) and vitrectomy in pediatric patients, with a focus on clinical indications, surgical techniques, outcomes, and complications across various pediatric ocular pathologies. Methods: A narrative review of published studies addressing the use of combined lensectomy and vitrectomy (LV) in pediatric patients was conducted. Conditions discussed include congenital cataracts, ectopia lentis, retinopathy of prematurity (ROP), retinal detachment (RD), and persistent fetal vasculature (PFV). Key surgical considerations, visual and anatomical outcomes, and postoperative complications were examined. Results: The literature search yielded a total of 160 articles, of which 43 met the inclusion criteria and were included in this review. Although lens-sparing vitrectomy (LSV) is preferred in many pediatric cases to preserve accommodation and reduce complications, combined LV is often necessary in advanced or complex diseases. Studies have shown that combined LV can achieve favorable anatomical outcomes, but functional visual recovery remains variable and is affected by factors such as patient age, baseline ocular anatomy, and disease severity. Postoperative complications such as glaucoma, visual axis opacification (VAO), and intraocular lens (IOL) dislocation are more frequent with combined procedures and require long-term follow-up and rehabilitation. Conclusions: Combined cataract surgery (or lensectomy) and vitrectomy may represent a valuable strategy in the management of complex pediatric ocular conditions, particularly when individualized to the clinical context. Tailored surgical approaches are essential to optimize anatomic and functional outcomes. Further prospective studies and harmonized multicenter registries are needed to develop evidence-based principles that can guide individualized surgical decision-making in this unique patient population.


  • E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer

    by Shirley Jusino, Yainyrette Rivera-Rivera, Camille Chardón-Colón, Armando J Ruiz-Justiz, Jaleisha Vélez-Velázquez, Angel Isidro, Melanie E Cruz-Robles, Margarita Bonilla-Claudio, Guillermo N Armaiz-Pena, Harold I Saavedra

    E2F3 is a transcription factor that may initiate tumorigenesis if overexpressed. Previously, we demonstrated that E2F3 mRNA is overexpressed in breast cancer and that E2F3 overexpression results in centrosome amplification and unregulated mitosis, which can promote aneuploidy and chromosome instability to initiate and sustain tumors. Further, we demonstrated that E2F3 leads to overexpression of the mitotic regulator Shugoshin-1, which until recently had unknown roles in cancer. This study aims to evaluate the roles of E2F3 and Shugoshin-1 in breast cancer metastatic potential. Here we demonstrated that E2F3 and Shugoshin-1 silencing leads to reduced cell invasion and migration in two mesenchymal triple-negative breast cancer (TNBC) cell lines (MDA-MB-231 and Hs578t). Moreover, E2F3 and Shugoshin-1 modulate the expression of epithelial-to-mesenchymal transition-associated genes such as Snail, E-Cadherin, and multiple matrix metalloproteinases. Furthermore, E2F3 depletion leads to reductions in tumor growth and metastasis in NOD-scid Gamma mice. Results from this study suggest a key role for E2F3 and a novel role for Shugoshin-1 in metastatic progression. These results can further help in the improvement of TNBC targeted therapies by interfering with pathways that intersect with the E2F3 and Shugoshin-1 signaling pathways.


  • Open Access

    DAMPs‐coated Prussian blue nanoparticles as photothermal‐nanoimmunotherapy agents for cancer

    by Armando Javier Ruiz‐Justiz, Juliana Cano‐Mejia, Rohan Fernandes